Mologen is a biotechnology company that develops novel drugs for cancer immunotherapy... Read more
Mologen is a biotechnology company that develops novel drugs for cancer immunotherapy... Read more
Est. Annual Revenue
<$1M
Est. Employees
<10
News
May 08, 2020
centralcharts
Press Release: Mologen Ag : DGAP-Adhoc: MOLOGEN AG: Sale of the essential assets
Apr 30, 2020
MarketScreener
Mologen Ag: MOLOGEN AG: Resignation of all Management and Supervisory Board members
Apr 23, 2020
MarketScreener
Mologen Ag: MOLOGEN AG: Revocation of admission to Prime Standard
Feb 03, 2020
BioPortfolio
Mologen Ag: MOLOGEN AG Opening of insolvency proceedings
Dec 03, 2019
BioPortfolio
Mologen Ag: MOLOGEN AG Insolvency Filing
Dec 03, 2019
centralcharts
Press Release: Mologen Ag : DGAP-Adhoc: MOLOGEN AG: Insolvency Filing
Nov 07, 2019
BioPortfolio
Mologen Ag: MOLOGEN AG Focusing on combination therapies
Oct 31, 2019
FE Investegate
Mologen Ag: MOLOGEN AG : Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Oct 30, 2019
FE Investegate
Mologen Ag: MOLOGEN AG : Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
Sep 30, 2019
BioPortfolio
Mologen Ag: MOLOGEN AG Update on development status of lead product candidates